---
created: 2025-04-13
updated: 2025-04-13T10:51
id: c5evb=$T64
specialty: cardio
specialty_id: 207
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::
  - theme/b&b::03-biochem::05-lipids::03-lipid-drugs
  - source/ak-step1-v11::
  - theme/firstaid::05-pharmacology::03-toxicities-&-side-effects::02-drug-reactions---cardiovascular
  - source/ak-step1-v11::
  - theme/firstaid::07-cardiovascular::05-pharm::10-lipid-lowering-agents::niacin
  - source/ak-step1-v11::
  - theme/nbme::27
  - source/ak-step1-v11::
  - source/ome-banner::basic-science::02-metabolism
  - source/ak-step1-v11::
  - theme/physeo::05-biochem::05-metabolism::28-nutrition
  - source/ak-step1-v11::
  - theme/physeo::05-biochem::05-metabolism::31-niacin-(b3)---nutrition
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::10-cardiac::13-niacin
  - source/ak-step1-v11::
  - theme/sketchypharm::03-blood-&-inflammation::02-dyslipidemia-drugs::03-fibrates,-niacin
  - source/ak-step1-v11::
  - theme/uworld::100-999::100-199::160
  - source/ak-step1-v11::^other::^highyield::1-highyield
  - source/ak-step1-v11::^systems::cardio::pharmacology"
type: flashcard
---

# Question
A common adverse effect associated with niacin is cutaneous **flushing** and **warmth** due to increased **prostaglandin** activity

---

# Answer
